WallStreetZenWallStreetZen

NASDAQ: PRVA
Privia Health Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for PRVA

Based on 10 analysts offering 12 month price targets for Privia Health Group Inc.
Min Forecast
$21.00+24.26%
Avg Forecast
$25.00+47.93%
Max Forecast
$30.00+77.51%

Should I buy or sell PRVA stock?

Based on 10 analysts offering ratings for Privia Health Group Inc.
Strong Buy
Strong Buy
5 analysts 50%
Buy
3 analysts 30%
Hold
2 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PRVA stock forecasts and price targets.

PRVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-15
lockedlocked$00.00+00.00%2024-05-10
lockedlocked$00.00+00.00%2024-05-01
lockedlocked$00.00+00.00%2024-04-22
lockedlocked$00.00+00.00%2024-03-06
Barclays
Top 29%
72
HoldInitiates Coverage On$22.00+30.18%2024-03-06
TD Cowen
Bottom 9%
9
BuyMaintains$26.00+53.85%2024-03-01
Evercore ISI Group
Bottom 4%
4
BuyMaintains$25.00+47.93%2024-02-28
Bank of America
Top 30%
71
HoldDowngrades$21.00+24.26%2024-02-22
JMP Securities
Bottom 1%
1
BuyInitiates Coverage On$27.00+59.76%2023-12-06

1 of 1

Forecast return on equity

Is PRVA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.27%

Forecast return on assets

Is PRVA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PRVA revenue forecast

What is PRVA's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$1.7B-1.63%
Avg 2 year Forecast
$1.9B+13.07%
Avg 3 year Forecast
$2.2B+28.99%
PRVA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PRVA earnings growth forecast

How is PRVA forecast to perform vs Health Information Services companies and vs the US market?
Company
60.28%
Industry
27.49%
Market
18.21%
PRVA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PRVA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PRVA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PRVA revenue growth forecast

How is PRVA forecast to perform vs Health Information Services companies and vs the US market?
Company
8.77%
Industry
12.94%
Market
9.95%
PRVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PRVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PRVA vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
PRVA$16.90$25.00+47.93%Strong Buy
PINC$19.66$21.88+11.27%Hold
BTSG$11.47$15.94+39.01%Strong Buy
TDOC$12.73$18.68+46.73%Buy
SDGR$22.76$35.71+56.92%Buy
View Top Health Information Service Stocks

Privia Health Group Stock Forecast FAQ

Is Privia Health Group Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: PRVA) stock is to Strong Buy PRVA stock.

Out of 10 analysts, 5 (50%) are recommending PRVA as a Strong Buy, 3 (30%) are recommending PRVA as a Buy, 2 (20%) are recommending PRVA as a Hold, 0 (0%) are recommending PRVA as a Sell, and 0 (0%) are recommending PRVA as a Strong Sell.

If you're new to stock investing, here's how to buy Privia Health Group stock.

What is PRVA's revenue growth forecast for 2024-2026?

(NASDAQ: PRVA) Privia Health Group's forecast annual revenue growth rate of 8.77% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 12.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Privia Health Group's revenue in 2024 is $1,686,704,000.On average, 7 Wall Street analysts forecast PRVA's revenue for 2024 to be $197,978,904,830, with the lowest PRVA revenue forecast at $196,048,700,682, and the highest PRVA revenue forecast at $201,050,503,110. On average, 7 Wall Street analysts forecast PRVA's revenue for 2025 to be $227,548,243,513, with the lowest PRVA revenue forecast at $223,996,510,382, and the highest PRVA revenue forecast at $232,920,289,093.

In 2026, PRVA is forecast to generate $259,602,733,459 in revenue, with the lowest revenue forecast at $252,559,999,960 and the highest revenue forecast at $269,634,377,999.

What is PRVA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PRVA) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of N/A.

What is PRVA's Price Target?

According to 10 Wall Street analysts that have issued a 1 year PRVA price target, the average PRVA price target is $25.00, with the highest PRVA stock price forecast at $30.00 and the lowest PRVA stock price forecast at $21.00.

On average, Wall Street analysts predict that Privia Health Group's share price could reach $25.00 by May 15, 2025. The average Privia Health Group stock price prediction forecasts a potential upside of 47.93% from the current PRVA share price of $16.90.

What is PRVA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PRVA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.